Alzheimer's Disease

On this edition of our program, we learn about the Oklahoma Healthy Aging Initiative, or OHAI, which was, per its website, "established in 2012 by a grant from the Donald W. Reynolds Foundation. OHAI understands that good health is key to successful aging. We focus in improving the health of older adults across the state through caregiver-training and health-promotion education. We also partner with health systems to establish senior health clinics to increase access to geriatric health care.

Alzheimer's Disease is the 6th leading cause of death in the United States. More than 5 million Americans are living with Alzheimer's -- and by 2050, this number could be as high as 16 million. Alzheimer's Disease kills more people annually than breast cancer and prostate cancer combined. And every 66 seconds, someone in the U.S. develops Alzheimer's Disease.

Do you happen to know, among your circle of friends and relatives and colleagues, a "pack rat" or two -- i.e., people who just can't seem to throw things away? On this edition of StudioTulsa Medical Monday, we offer a discussion of compulsive hoarding, which is an anxiety disorder affecting a great many Americans that makes it quite difficult for someone to discard with possessions, regardless of the actual value of those possessions.

On this edition of ST, we speak with the popular New Yorker cartoonist and bestselling author Roz Chast about her latest book, an award-winning graphic memoir called "Can't We Talk about Something More Pleasant?" It's a book that is, as Michiko Kakutani noted in The New York Times, "by turns grim and absurd, deeply poignant and laugh-out-loud funny. Ms.

On this edition of ST, as the week-long 2013 Alzheimer's Association International Conference comes to end up in Boston, we speak with Mark Fried, the president and CEO of the Oklahoma Chapter of the Alzheimer's Association. Fried tells us about some interesting new studies and findings that were discussed at this year's conference, namely those related to: the risk and prevention of Alzheimer's disease; advances in early detection; and clinical trials and ongoing therapies.